AH

Alexander Hird

AA Astrazeneca Ab: 8 patents #153 of 1,971Top 8%
CT C4 Therapeutics: 3 patents #17 of 35Top 50%
Overall (All Time): #438,386 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12421220 Bicyclic-substituted glutarimide cereblon binders Christopher G. Nasveschuk, Kiel Lazarski, Yanke Liang, Ning Yin, Andrew C. Good +3 more 2025-09-23
12371442 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Ryan E. Michael, Kiel Lazarski +5 more 2025-07-29
11673902 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Ryan E. Michael, Kiel Lazarski +5 more 2023-06-13
11472816 Mcl-1 inhibitors and methods of use thereof Matthew BELMONTE, Wenzhan Yang, Paul SECRIST, Daniel W. ROBBINS, Steven Kazmirski +6 more 2022-10-18
11352369 Pyridine and pyrimidine derivatives Bernard Christophe Barlaam, Christopher De Savi, Janet Hawkins, Michelle Lamb, Kurt Gordon Pike +1 more 2022-06-07
11149024 Synthesis of Mcl-1 inhibitor Craig Stewart, Simon Hardy, Andrew Stark, Qing Ye, Xiaolan Zheng +3 more 2021-10-19
10889594 MCL-1 inhibitors and methods of use thereof Wenzhan Yang, Daniel W. ROBBINS, Steven Kazmirski, Dedong Wu, Bo Peng +4 more 2021-01-12
10717746 Chemical compounds Bernard Christophe Barlaam, Christopher De Savi, Janet Hawkins, Michelle Lamb, Kurt Gordon Pike +1 more 2020-07-21
10196404 MCL-1 inhibitors and methods of use thereof Matthew BELMONTE, Wenzhan Yang, Paul SECRIST, Daniel W. ROBBINS, Steven Kazmirski +6 more 2019-02-05
9845331 Chemical compounds Bernard Christophe Barlaam, Christopher De Savi, Janet Hawkins, Michelle Lamb, Kurt Gordon Pike +1 more 2017-12-19
9840518 MCL-1 inhibitors and methods of use thereof Wenzhan Yang, Daniel W. ROBBINS, Steven Kazmirski, Dedong Wu, Bo Peng +2 more 2017-12-12